EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer

Qiaomu Tian iD, Peng Zhang, Yihan Wang, Youhui Si, Dengping Yin, Christopher R Weber, Melissa L Fishel, Karen E Pollok, Bo Qiu, Fei Xiao, Anita S Chong iD

eLife · 2023

DOI: 10.7554/elife.85862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Qiaomu Tian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The University of Chicago, Chicago, United States. Hauptthemen laut MEDLINE: Diterpenes, Antineoplastic Agents, Pancreatic Neoplasms, Prodrugs. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cinkate Pharmaceutical Corp.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is the seventh leading cause of cancer-related death worldwide, and despite advancements in disease management, the 5 -year survival rate stands at only 12%. Triptolides have potent anti-tumor activity against different types of cancers, including pancreatic cancer, however poor solubility and toxicity limit their translation into clinical use. We synthesized a novel pro-drug of triptolide, ( E )–19-[(1’-benzoyloxy-1’-phenyl)-methylidene]-Triptolide (CK21), which was formulated into an emulsion for in vitro and in vivo testing in rats and mice, and used human pancreatic cancer cell lines and patient-derived pancreatic tumor organoids. A time-course transcriptomic profiling of tumor organoids treated with CK21 in vitro was conducted to define its mechanism of action, as well as transcriptomic profiling at a single time point post-CK21 administration in vivo. Intravenous administration of emulsified CK21 resulted in the stable release of triptolide, and potent anti-proliferative effects on human pancreatic cancer cell lines and patient-derived pancreatic tumor organoids in vitro, and with minimal toxicity in vivo. Time course transcriptomic profiling of tumor organoids treated with CK21 in vitro revealed

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiterpenesAntineoplastic AgentsPancreatic NeoplasmsProdrugsPhenanthrenesHumansMiceRatsAnimalsNF-kappa BSignal TransductionCell Line, TumorApoptosisEpoxy Compounds

Stichwörter der Autor:innen

apotosiscancer biologydrug developmentmousepancreatic cancertriptolide

Substanzen

NF-kappa BtriptolideDiterpenesAntineoplastic AgentsEpoxy CompoundsProdrugsPhenanthrenes

Autor:innen und Institutionen

  • Department of Surgery, The University of Chicago, Chicago, United States.
  • Cinkate Pharmaceutical Corp, ZhangJiang District, Shanghai, China.
  • Department of Pathology, The University of Chicago, Chicago, United States.
  • Department of Pediatrics, Indiana University, Indianapolis, United States.

ORCID-Profile: Qiaomu Tian, Anita S Chong

Förderung

  • Cinkate Pharmaceutical Corp

Zitieren

APA

Tian, Q., Zhang, P., Wang, Y., Si, Y., Yin, D., Weber, C. R., Fishel, M. L., Pollok, K. E., Qiu, B., Xiao, F., & Chong, A. S. (2023). A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer. eLife. https://doi.org/10.7554/elife.85862

Vancouver

Tian Q, Zhang P, Wang Y, Si Y, Yin D, Weber CR, et al. A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer. eLife. 2023. doi:10.7554/elife.85862

BibTeX
@article{Tian2023,
  author = {Tian, Qiaomu and Zhang, Peng and Wang, Yihan and Si, Youhui and Yin, Dengping and Weber, Christopher R and Fishel, Melissa L and Pollok, Karen E and Qiu, Bo and Xiao, Fei and Chong, Anita S},
  title = {A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer},
  journal = {eLife},
  year = {2023},
  doi = {10.7554/elife.85862}
}
Kostenlos starten →